New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Ultra-high purity surfactant for biologics and parenteral drug formulations
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Subscribe To Our Newsletter & Stay Updated
